Sean Bohen - Net Worth and Insider Trading

Sean Bohen Net Worth

The estimated net worth of Sean Bohen is at least $1 Million dollars as of 2024-12-01. Sean Bohen is the PRESIDENT AND CEO of Olema Pharmaceuticals inc and owns about 144,925 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $1 Million. Details can be seen in Sean Bohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Bohen has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sean Bohen

To

Sean Bohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean Bohen owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .

Click here to see the complete history of Sean Bohen’s form 4 insider trades.

Insider Ownership Summary of Sean Bohen

Ticker Comapny Transaction Date Type of Owner
OLMA Olema Pharmaceuticals inc 2023-11-22 director & President and CEO

Sean Bohen Latest Holdings Summary

Sean Bohen currently owns a total of 1 stock. Sean Bohen owns 144,925 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $1 Million.

Latest Holdings of Sean Bohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OLMA Olema Pharmaceuticals inc 2023-11-22 144,925 10.12 1,466,641

Holding Weightings of Sean Bohen


Sean Bohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean Bohen has made a total of 5 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 57,225 shares on November 22, 2023, which brought Sean Bohen around $824,040.

Insider Trading History of Sean Bohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean Bohen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sean Bohen Ownership Network

Ownership Network List of Sean Bohen

No Data

Ownership Network Relation of Sean Bohen

Insider Network Chart

Sean Bohen Owned Company Details

What does Olema Pharmaceuticals inc do?

Who are the key executives at Olema Pharmaceuticals inc?

Sean Bohen is the director & President and CEO of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and Chief Development Officer David C. Myles .

Olema Pharmaceuticals inc (OLMA) Insider Trades Summary

Over the past 18 months, Sean Bohen made 1 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 57,225. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 1,710,000 shares made by G. Walmsley Graham .

In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,223,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 2,977,142 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Olema Pharmaceuticals inc Insider Transactions

No Available Data

Sean Bohen Mailing Address

Above is the net worth, insider trading, and ownership report for Sean Bohen. You might contact Sean Bohen via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.

Discussions on Sean Bohen

No discussions yet.